Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Antonia

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Oncoimmunology|June 27, 2013
Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancerBen C Creelan, Scott Antonia, Gerold Bepler, et al.
Cytotherapy|July 21, 2025
Improving lung cancer tumor-infiltrating lymphocyte (TIL) manufacturingPamela K Noldner, Ying Zhou, Liliana Lyniv, et al.
Oncology|July 16, 2005
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancerAlberto Chiappori, George Simon, Charles Williams, et al.
Cancer|October 27, 2011
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysisGeorge R Simon, Michael J Schell, Mubeena Begum, et al.
Oncotarget|March 9, 2018
A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancerHatem Soliman, Fatema Khambati, Hyo S Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 25, 2023
Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFICJarushka Naidoo, Scott Antonia, Yi-Long Wu, et al.
The Journal of Clinical Investigation|March 18, 2010
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in miceRupal Ramakrishnan, Deepak Assudani, Srinivas Nagaraj, et al.
Journal of Thoracic Disease|January 10, 2019
Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosisDerek Nichols, Theresa A Boyle, David Noyes, et al.
British Journal of Cancer|July 15, 2016
Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lungLary A Robinson, Crystal J Jaing, Christine Pierce Campbell, et al.
British Journal of Cancer|October 21, 2016
Reply to: Comment on 'Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung'Lary A Robinson, Crystal J Jaing, Christine Pierce Campbell, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Oncoimmunology|June 27, 2013
Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancerBen C Creelan, Scott Antonia, Gerold Bepler, et al.
Cytotherapy|July 21, 2025
Improving lung cancer tumor-infiltrating lymphocyte (TIL) manufacturingPamela K Noldner, Ying Zhou, Liliana Lyniv, et al.
Oncology|July 16, 2005
Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancerAlberto Chiappori, George Simon, Charles Williams, et al.
Cancer|October 27, 2011
Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysisGeorge R Simon, Michael J Schell, Mubeena Begum, et al.
Oncotarget|March 9, 2018
A phase-1/2 study of adenovirus-p53 transduced dendritic cell vaccine in combination with indoximod in metastatic solid tumors and invasive breast cancerHatem Soliman, Fatema Khambati, Hyo S Han, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 25, 2023
Brief Report: Durvalumab After Chemoradiotherapy in Unresectable Stage III EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFICJarushka Naidoo, Scott Antonia, Yi-Long Wu, et al.
The Journal of Clinical Investigation|March 18, 2010
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in miceRupal Ramakrishnan, Deepak Assudani, Srinivas Nagaraj, et al.
Journal of Thoracic Disease|January 10, 2019
Evaluation of combined anti-PD-1 immunotherapy and radiation therapy in a preclinical mouse model of pneumonitis and fibrosisDerek Nichols, Theresa A Boyle, David Noyes, et al.
British Journal of Cancer|July 15, 2016
Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lungLary A Robinson, Crystal J Jaing, Christine Pierce Campbell, et al.
British Journal of Cancer|October 21, 2016
Reply to: Comment on 'Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung'Lary A Robinson, Crystal J Jaing, Christine Pierce Campbell, et al.
Pageof 9